iCAD plans to supply lung cancer software

Article

Software developer iCAD and image processing specialist TeraRecon have signed a nonexclusive product licensing and distribution agreement under which TeraRecon will develop a new server-based product offering to include iCAD lung cancer detection,

Software developer iCAD and image processing specialist TeraRecon have signed a nonexclusive product licensing and distribution agreement under which TeraRecon will develop a new server-based product offering to include iCAD lung cancer detection, analysis, and tracking software. Product release is expected in 2005. The stand-alone server product will work in concert with existing PACS and DICOM review equipment, as well as other products in the TeraRecon Aquarius product line. The three-year agreement provides for worldwide distribution through TeraRecon's direct sales force, independent resellers/distributors, and OEM partnerships. The companies have agreed to work together to obtain the FDA approvals necessary for U.S. distribution.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.